A Case of Mixed Fungemia with Cryptococcus laurentii and Candida zeylanoides.
- Author:
Chang Jae LEE
1
;
Jong Hee SHIN
;
Jong Phil KIM
;
Hoon KOOK
;
Soon Pal SUH
;
Dong Wook RYANG
Author Information
1. Department of Clinical Pathology Pediatrics, Chonnam National University Medical School, Gwangju, Korea.
- Publication Type:In Vitro ; Case Report
- Keywords:
Cryptococcus laurentii;
Candida zeylanoides;
Fungemia;
Central venous catheter
- MeSH:
Amphotericin B;
Candida*;
Catheters;
Central Venous Catheters;
Child;
Cryptococcus*;
Drug Therapy;
Female;
Fluconazole;
Fungemia*;
Humans;
Korea;
Length of Stay;
Leukemia, Myeloid, Acute;
Remission Induction
- From:Korean Journal of Clinical Pathology
2001;21(4):282-286
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Cryptococcus laurentii is one of several non-neoformans cryptococci that have rarely been associated with human infection. Candida zeylanoides, an unusual Candida species, is also infrequently reported as a human pathogen. We report a case of mixed fungemia with C. laurentii and C. zeylanoides in a 12-year-old girl. The patient with acute myelogenous leukemia was receiving intensive remission induction chemotherapy through a central venous catheter (CVC) and was severely neutropenic. She had been treated with oral fluconazole prophylaxis since admission. C. laurentii and C. zeylanoides were simultaneously isolated from the peripheral blood cultures collected on days 29 and 31 of her hospital stay. The culture of the removed catheter tip grew >15 CFU of both C. laurentii and C. zeylanoides. In vitro susceptibility testing of the strains showed that the MIC of fluconazole for C. laurentii and C. zeylanoides were 8 microgram/mL and 4 microgram/mL, respectively. The patient was successfully treated by CVC removal and by treatment with amphotericin B intravenously. To our knowledge, this represents the first report of C. laurentii and C. zeylanoides fungemia in Korea.
